InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by LEIDEN JEFFREY M, Président Exécutif. Officer active across 1 companies, notably Vertex Pharmaceuticals INC / MA. In total, 5 reports have been logged. Total volume traded: €4.2m. The latest transaction was disclosed on 13 April 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€4m15,789 shares@ €265.25780.0038% mcap50.3% of flow
Common Stock
SEC:0000899243-22-014805:0·
€2m12,141 shares@ €201.54450.0022% mcap29.4% of flow
Common Stock
SEC:0000899243-22-008119:0·
€2m8,236 shares@ €204.39950.0015% mcap20.2% of flow
Common Stock
SEC:0000899243-22-007209:0·
028,444 shares0
Common Stock
SEC:0001209191-22-006779·
028,444 shares0
Common Stock
SEC:0001209191-22-006779:0·
5 of 5 declarations
About LEIDEN JEFFREY M
Jeffrey M. Leiden serves as Executive Chairman of Vertex Pharmaceuticals Inc. / MA. In this role, he oversees the company's overall strategy and ensures innovation in the biopharmaceutical sector. Leiden brings extensive experience in management and product development, which is essential for Vertex's growth. His commitment to excellence and strategic vision are assets to the board.
